SPRUCE BIOSCIENCES, INC.

For the period ended Sep 30, 2025. Filed Nov 10, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 10, 2025

SPRB$46.55+9.0%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Balance Sheets

(in thousands, except share and per share amounts)

	September 30,	December 31,
	2025	2024
ASSETS
Current assets:
Cash and cash equivalents	$10,669	$38,753
Prepaid expenses	932	3,177
Other current assets	2,915	2,276
Total current assets	14,516	44,206
Right-of-use assets	735	934
Other assets	62	69
Total assets	$15,313	$45,209
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$1,386	$1,295
Accrued expenses and other current liabilities	7,502	12,329
Term loan, current portion	539	1,622
Total current liabilities	9,427	15,246
Lease liabilities, net of current portion	500	736
Term loan, net of current portion	—	124
Other liabilities	—	282
Total liabilities	9,927	16,388
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued or outstanding as of September 30, 2025 and December 31, 2024	—	—
Common stock, $0.0001 par value; 200,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 563,491 and 563,042 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	—	—
Additional paid-in capital	279,974	279,089
Accumulated deficit	(274,588)	(250,268)
Total stockholders’ equity	5,386	28,821
Total liabilities and stockholders’ equity	$15,313	$45,209

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.